Literature DB >> 20375619

Structural insights into the recognition properties of human ficolins.

Virginie Garlatti1, Lydie Martin, Monique Lacroix, Evelyne Gout, Gérard J Arlaud, Nicole M Thielens, Christine Gaboriaud.   

Abstract

Innate immunity relies upon the ability of a variety of recognition molecules to sense pathogens through conserved molecular signatures that are often carbohydrates. Ficolins are oligomeric proteins assembled from collagen-like stalks and fibrinogen-like domains that have the ability to sense these molecular patterns on both pathogens and apoptotic cell surfaces. Three ficolins, termed L, H and M, have been identified in humans. They differ in their localization and concentration in extracellular fluids, their mode of secretion and their recognition properties. From a structural point of view, ficolins are assembled from basal trimeric subunits comprising a collagen-like triple helix and a globular domain composed of 3 fibrinogen-like domains. The globular domains are responsible for sensing danger signals whereas the collagen-like stalks provide a link with immune effectors. This review mainly focuses on the structure and recognition properties of the 3 human ficolins, as revealed by recent crystallographic analysis of their recognition domains. The ligand binding sites have been identified in the 3 ficolins and their recognition mechanisms have been characterized at the atomic level. In the case of M-ficolin, a structural transition at acidic pH disables the binding pocket, and thus likely participates in the functional cycle of this protein. (c) 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20375619     DOI: 10.1159/000233475

Source DB:  PubMed          Journal:  J Innate Immun        ISSN: 1662-811X            Impact factor:   7.349


  14 in total

1.  Low invasiveness of pneumococcal serotype 11A is linked to ficolin-2 recognition of O-acetylated capsule epitopes and lectin complement pathway activation.

Authors:  Allison M Brady; Juan J Calix; Jigui Yu; Kimball Aaron Geno; Gary R Cutter; Moon H Nahm
Journal:  J Infect Dis       Date:  2014-03-27       Impact factor: 5.226

2.  Blood collection tubes influence serum ficolin-1 and ficolin-2 levels.

Authors:  Allison M Brady; Brady L Spencer; Ann R Falsey; Moon H Nahm
Journal:  Clin Vaccine Immunol       Date:  2013-10-30

Review 3.  Correlating structure and function during the evolution of fibrinogen-related domains.

Authors:  Russell F Doolittle; Kyle McNamara; Kevin Lin
Journal:  Protein Sci       Date:  2012-12       Impact factor: 6.725

4.  Enhancement of Ebola Virus Infection via Ficolin-1 Interaction with the Mucin Domain of GP Glycoprotein.

Authors:  Anne-Laure Favier; Evelyne Gout; Olivier Reynard; Olivier Ferraris; Jean-Philippe Kleman; Viktor Volchkov; Christophe Peyrefitte; Nicole M Thielens
Journal:  J Virol       Date:  2016-05-12       Impact factor: 5.103

5.  Role of ficolin-A and lectin complement pathway in the innate defense against pathogenic Aspergillus species.

Authors:  Stefan Bidula; Hany Kenawy; Youssif M Ali; Darren Sexton; Wilhelm J Schwaeble; Silke Schelenz
Journal:  Infect Immun       Date:  2013-03-11       Impact factor: 3.441

Review 6.  Host restriction factors for hepatitis C virus.

Authors:  Li-Ya Zhou; Lei-Liang Zhang
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

7.  Human H-ficolin inhibits replication of seasonal and pandemic influenza A viruses.

Authors:  Anamika Verma; Mitchell White; Vinod Vathipadiekal; Shweta Tripathi; Julvet Mbianda; Micheal Ieong; Li Qi; Jeffery K Taubenberger; Kazue Takahashi; Jens C Jensenius; Steffen Thiel; Kevan L Hartshorn
Journal:  J Immunol       Date:  2012-07-30       Impact factor: 5.422

8.  Carbohydrate recognition properties of human ficolins: glycan array screening reveals the sialic acid binding specificity of M-ficolin.

Authors:  Evelyne Gout; Virginie Garlatti; David F Smith; Monique Lacroix; Chantal Dumestre-Pérard; Thomas Lunardi; Lydie Martin; Jean-Yves Cesbron; Gérard J Arlaud; Christine Gaboriaud; Nicole M Thielens
Journal:  J Biol Chem       Date:  2009-12-23       Impact factor: 5.157

Review 9.  Human L-ficolin (ficolin-2) and its clinical significance.

Authors:  David C Kilpatrick; James D Chalmers
Journal:  J Biomed Biotechnol       Date:  2012-02-28

Review 10.  Putting the structure into complement.

Authors:  Susan M Lea; Steven Johnson
Journal:  Immunobiology       Date:  2012-11       Impact factor: 3.144

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.